Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Metropolis Healthcare...

    Metropolis Healthcare plans Rs 100 crore expansion

    Written by Ruby Khatun Khatun Published On 2018-02-19T10:45:52+05:30  |  Updated On 19 Feb 2018 10:45 AM IST
    Metropolis Healthcare plans Rs 100 crore expansion

    New Delhi: Diagnostic chain Metropolis Healthcare has drawn up a Rs 100-crore capex plan to open 30 labs and 700 collection centres, apart from entering the African market, a top company official has said.


    "We have 2,000 collection centres now and are adding 700 more along with 30 laboratories over the next 12 months. We are already present in four countries and is entering two more African markets," promoter and managing director Ameera Shah told PTI.


    Currently, the lab chain has 2,000 collection centres and 150 labs across the country and Sri Lanka, Kenya, Mauritius and Ghana.


    The company would strengthen its presence in Southern and Western states and expand to the Northeast where it does not have much presence, Shah said, adding they have already identified a lab for acquisition in Gujarat.


    The company will invest around Rs 100 crore for expansion, medical equipment and IT development, she said, adding the capex will be funded through internal accruals. She also ruled out hitting the capital markets for funds saying they have no plans to raise money through an initial public offer in the near future.


    As part of the public-private partnership, programme, they were recently awarded a contract by the National Aids Control Organisation (Naco) under the Union health ministry to conduct an HIV viral load-testing across 525 antiretroviral therapy (ART) centres in the country.


    The project will bring about a sweeping change in the way HIV patients are treated in the country now, she claimed.


    Shah pointed said the domestic diagnostic market is growing at 10-11 percent annually and is expected to grow further due to the government thrust on affordable healthcare plans announced in the Budget.


    The chain offers comprehensive testing in the areas of genetics biochemistry, molecular oncology, anatomic pathology, microbiology, hematology, and immunochemistry among others.


    Of late, Metropolis has also expanded into new service lines like clinical trials, hospital lab management, lab-at-home services, preventive health check-ups and corporate and wellness solutions.


    Metropolis processes 30 million tests a year catering to over 20,000 labs, hospitals and nursing homes and 2 lakh consultants.

    African marketAmeera Shahcapexdiagnostic chainExpansionHIVinitial public offermedical equipmentMetropolisMetropolis Healthcare
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok